Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wim Wilpshaar
A Phase 3 Randomized Placebo-Controlled Trial to Assess the Efficacy and Safety of Ipragliflozin as an Add-On Therapy to Metformin in Russian Patients With Inadequately Controlled Type 2 Diabetes Mellitus
Diabetes Research and Clinical Practice
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Safety of Ipragliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase II/III/IV Clinical Trials
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Efficacy and Safety of Ipragliflozin Add‐on Therapy to Insulin in Japanese Patients With Type 1 Diabetes Mellitus: A Randomized, Double‐blind, Phase 3 Trial
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus
Global Journal of Endocrinological Metabolism
Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Effect of Adding Insulin Degludec to Treatment in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Liraglutide: A Double-Blind Randomized Controlled Trial (BEGIN: ADD TO GLP-1 Study)
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Efficacy and Safety of Once-Weekly Semaglutide Versus Daily Canagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes (SUSTAIN 8): A Double-Blind, Phase 3b, Randomised Controlled Trial
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Methotrexate Add-On Therapy Versus Placebo for Patients With Chronic Spontaneous Urticaria Resistant to H1-Antihistamines: A Randomized, Controlled Trial
Journal of the American Academy of Dermatology
Dermatology
Efficiency and Safety of Transfer of Type 2 Diabetes Patients Inadequately Controlled on Metformin Alone to Combined Therapy Withmetformin and Diabeton MB
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes